Article Finder
Browse our vast collection of articles. Simply select a category on the left and find a list of related articles on the right.
Article Category
Article Title
- High or Low Blood Pressure May Raise the Risk of Dementia
- How Alcohol Might Affect Your Dementia Risk
- The Hidden Costs of Alzheimer’s Disease
- Susceptible to Scams? It May Be an Early Sign of Alzheimer’s Disease
- Alzheimer’s Caregivers May Benefit from Happiness Training
- Giving Up the Guns When a Family Member Has Alzheimer’s
- Care Management Program Is Reducing Need for Anti-anxiety Medication and Visits to the Hospital/Emergency Room
- Talking to a Loved One With Alzheimer’s
- 10 Powerful Ways to Commemorate Alzheimer’s Awareness Month
- Making the Most of Mealtimes for People With Alzheimer’s
- FOR MORE ARTICLES CLICK HERE
- Depression Increases the Risk of Alzheimer’s Disease
- Poor Sleep Tied to Rise in Alzheimer’s Protein in Blood
- Air Pollution Tied to Alzheimer’s Brain Changes
- The Tau of Alzheimer’s
- Anemia Tied to Alzheimer’s Risk
- ‘Squeezed’ Blood Vessels in the Brain May Contribute to Alzheimer’s Onset
- Hormone Therapy for Prostate Cancer Tied to Alzheimer’s Disease Risk
- Lack of Deep Sleep Tied to Alzheimer’s Brain Changes
- Inflammation in Middle Age Tied to Thinking and Memory Problems Later
- Frailty May Increase Susceptibility to Alzheimer’s Disease
- FOR MORE ARTICLES CLICK HERE
- Take Your Blood Pressure Meds. It May Reduce Your Alzheimer’s Risk.
- Drug Company to Pursue Approval of Aducanumab, New Drug for Alzheimer’s
- Drugs May Not Be the Best Choice for Easing the Agitation of Alzheimer’s
- Alzheimer’s Drug May Lead to Life-Threatening Muscle Disease
- Opioid Painkillers Increase Pneumonia Risk in People With Alzheimer’s Disease
- Drug Companies Halt Trials of Aducanumab for Alzheimer’s Disease
- Diabetes Treatments May Help Ward Off Alzheimer’s Disease
- Can Mushrooms Help Your Memory?
- Buyer Beware: Dietary Supplement’s Won’t Cure Alzheimer’s Disease
- Experimental Drug, Fails to Benefit Alzheimer’s Patients
- FOR MORE ARTICLES CLICK HERE
- Obesity at Midlife Tied to Increased Dementia Risk
- Reading and Writing May Be Good for the Brain
- Ski Study Shows How Exercise May Aid the Brain
- How Light May Help People with Alzheimer’s Disease
- Trans Fats Tied to Increased Alzheimer’s Risk
- New Guidelines Urge a Healthy Lifestyle to Prevent Dementia
- At Genetic Risk for Alzheimer’s Disease? A Healthy Lifestyle May Help
- Exercise Can Help Keep the Brain ‘Young’
- Fighting Gum Disease May Aid in Fight Against Alzheimer’s Disease
- Brain Scans Aid in Management of Alzheimer’s Disease
- FOR MORE ARTICLES CLICK HERE
- A Rare Genetic Mutation May Protect Against Alzheimer’s
- Income Drops in Young Adulthood May Impair Brain Health
- Blood Test for Alzheimer’s Grows Closer
- Are We Getting Closer to an Alzheimer’s Vaccine?
- Why More Women Than Men Have Alzheimer’s Disease
- Scientists get a ‘total surprise’ and a promising new clue for how to cure Alzheimer’s
- Some 44 Million People Have Alzheimer’s Worldwide
- Nearly 14 Million Americans Will Have Alzheimer’s Disease by 2060
- Alzheimer’s Rates Could Double in Coming Decades
- Combining Care Program With Medication Reduces Alzheimer’s Symptoms By 750%
- FOR MORE ARTICLES CLICK HERE
- Lucretia V. Holden promoted to Executive Director at the Fisher Center
- The Fisher Center for Alzheimer’s Research Foundation Earns Coveted 4-Star Rating from Charity Navigator for the 8th Consecutive Year
- Fisher Center For Alzheimer’s Research Foundation Wins Fall 2018 Digital Health Awards®
- Fisher Center for Alzheimer’s Research Foundation Earns Gold Seal of Transparency from GuideStar
- The Fisher Center for Alzheimer’s Research Foundation Earns Coveted 4-Star Rating from Charity Navigator for the 7th Consecutive Year
- Hear Kent Karosen, President and CEO of the Fisher Center for Alzheimer’s Research Foundation, describe his new book and the power of art therapy
- Fisher Center Scientists link a Mutation That Protects Against the Development of Alzheimer’s Disease
- Newly Inducted Into the Basketball Hall of Fame, Shaquille O’Neal, Joins the Fisher Center for Alzheimer’s Research Foundation to Raise Funds for Groundbreaking Research in the Quest for a Cure
- Pat Summitt, legendary women’s basketball coach, dies at 64
- Celebrating the life of Nancy Reagan for her Impact on the Fight to end Alzheimer’s
- FOR MORE ARTICLES CLICK HERE
Drug Facts: Razadyne, Reminyl (galantamine)
August 3, 2010
Generic name: galantamine
Description
Comes in 4 mg (white), 8 mg (pink) and 12 mg (brown-orange) tablets. Also available as a liquid for those who cannot swallow tablets.
Why It’s Prescribed
To ease the symptoms of early Alzheimer’s. May improve, maintain, or slow the decline in memory, thinking, and activities of daily living, such as dressing, eating, or handling mail. However, it does not halt disease progression long term.
Who Benefits
People with mild to moderate Alzheimer’s disease. The earlier treatment is started, the more effective it may be. About half of patients who try the drug show slight improvements.
How it Works
Originally derived from daffodil bulbs, this drug slows the breakdown of acetylcholine, a chemical that aids memory by transmitting messages between brain cells. It also acts on nicotine receptors in the brain.
Dosage Guidelines
To start: 4 mg twice a day. Dosage should be increased slowly, with at least four weeks between each increase, to minimize side effects. Average daily dose: 16 to 24 mg, taken as two daily doses in the morning and evening. An extended-release formula is also available: It is taken as a single daily dose. Take with food and plenty of fluids to minimize side effects. The liquid form can be mixed with water, juice or soda. Take with food and plenty of fluids to minimize side effects. The liquid form can be mixed with water, juice or soda.
Onset of Effect
For those who respond, benefits typically appear within several weeks of starting the drug.
Storage
Store in a tightly sealed container away from heat, moisture and light. Do not freeze the liquid form.
Missed Dose
Take as soon as possible, or if it’s near the time for your next dose, skip the missed dose and resume your normal schedule. If you miss a dose for several days or longer, talk to your doctor, who may re-start you on a lower dose.
Long-term Use
The drug is taken long term and may move the clock back a few months, but the disease continues to progress. If the drug seems to stop working, your doctor may switch you to another Alzheimer’s drug.
Side Effects
Serious: No serious side effects.
Most common: Nausea, vomiting, diarrhea, loss of appetite, weight loss. Usually occur when starting the drug or when dosage is increased. In most people, side effects dissipate with time.
Less common: Fatigue, feeling lightheaded or dizzy, tremor, headaches, abdominal cramps, heartburn, depression, insomnia, drowsiness, runny nose, urinary tract infection or blood in the urine.
Precautions & Special Concerns
Be sure to drink enough fluids while taking this medication. People with serious liver or serious kidney disease should not take this drug. Those with mild liver or kidney problems should limit dose to 16 mg a day. Do not drive until you see how the medicine affects you, since it may cause drowsiness.
When to Call the Doctor
If you experience side effects or the drug seems to stop working.
In Case of Overdose: Symptoms & What to Do
Severe nausea and vomiting, increased salivation, sweating, slowed heartbeat, low blood pressure, irregular breathing, unconsciousness, muscle weakness. Call your doctor, emergency medical services, or poison control center immediately.
Drug Interactions
May interact with paroxetine (Paxil), an antidepressant, and some drugs for Parkinson’s disease. Antihistamines, antipsychotic drugs, and some drugs for incontinence may also diminish its effects.
Food Interactions
No known food interactions. Avoid alcohol while using this medicine.
Disease Interactions
Do not take if you have severe kidney or liver disease. Consult your doctor if you have asthma, lung disease, epilepsy or seizures, heart problems, an ulcer, or urinary tract problems.
Expert comment
“For some people with Alzheimer’s disease, this drug can lead to improvements that the family can see. In others, responses may only be detectable under special testing conditions, or there may be no measurable response at all. It is important that family members and physicians maintain realistic expectations for drug therapy and remember that, as with all current Alzheimer’s drugs, responses are generally only modest at best.” –Samuel E. Gandy, M.D., Ph.D., Scientific Advisory Board, Fisher Center for Alzheimer’s Research Foundation
